Farah A, Paul P, Khan A, Sarkar A, Laws S, Chaari A
Front Med (Lausanne). 2025; 12:1435030.
PMID: 40041456
PMC: 11876558.
DOI: 10.3389/fmed.2025.1435030.
Arsene D, Tchaptchet S, Hansen J
Gut Microbes. 2025; 17(1):2473518.
PMID: 40022675
PMC: 11875499.
DOI: 10.1080/19490976.2025.2473518.
Mohsen E, Haffez H, Ahmed S, Hamed S, El-Mahdy T
Mol Neurobiol. 2025; .
PMID: 39934561
DOI: 10.1007/s12035-025-04728-5.
Qin L, Lv W
Nutr J. 2025; 24(1):12.
PMID: 39849464
PMC: 11755847.
DOI: 10.1186/s12937-025-01075-y.
Ruple H, Haasis E, Bettenburg A, Maier C, Fritz C, Schule L
Gut Microbes. 2025; 17(1):2453019.
PMID: 39843997
PMC: 11758946.
DOI: 10.1080/19490976.2025.2453019.
Pathobiont-triggered induction of epithelial IDO1 drives regional susceptibility to Inflammatory Bowel Disease.
Spencer P, Wang J, Smith E, Spiga L, Simmons A, Kim T
bioRxiv. 2025; .
PMID: 39803424
PMC: 11722351.
DOI: 10.1101/2025.01.04.630951.
Pathobiont-induced suppressive immune imprints thwart T cell vaccine responses.
Hajam I, Tsai C, Gonzalez C, Caldera J, Lazaro Diez M, Du X
Nat Commun. 2024; 15(1):10335.
PMID: 39681568
PMC: 11649901.
DOI: 10.1038/s41467-024-54644-w.
Intestinal microbiome and myelodysplastic syndromes: Current state of knowledge and perspectives for future.
Simunic M, McGraw K, Pavletic S, Rashidi A
Semin Hematol. 2024; 61(6):442-448.
PMID: 39551677
PMC: 11646173.
DOI: 10.1053/j.seminhematol.2024.10.006.
Differential contributions of the gut microbiota and metabolome to pathomechanisms in ulcerative colitis: an analysis.
Poppe J, Boesmans L, Vieira-Silva S, Deroover L, Tito R, Vandeputte D
Gut Microbes. 2024; 16(1):2424913.
PMID: 39535140
PMC: 11562902.
DOI: 10.1080/19490976.2024.2424913.
Early subclinical stages of the inflammatory bowel diseases: insights from human and animal studies.
Kelly C, Sartor R, Rawls J
Am J Physiol Gastrointest Liver Physiol. 2024; 328(1):G17-G31.
PMID: 39499254
PMC: 11901386.
DOI: 10.1152/ajpgi.00252.2024.
polysaccharide fortifies intestinal mucus barrier to alleviate intestinal inflammation by modulating abundance.
Wang Y, Li C, Li J, Zhang S, Zhang Q, Duan J
Acta Pharm Sin B. 2024; 14(9):3901-3915.
PMID: 39309495
PMC: 11413673.
DOI: 10.1016/j.apsb.2024.06.002.
Elevated risk of adverse effects from foodborne contaminants and drugs in inflammatory bowel disease: a review.
Walraven T, Busch M, Wang J, Donkers J, Duijvestein M, van de Steeg E
Arch Toxicol. 2024; 98(11):3519-3541.
PMID: 39249550
PMC: 11489187.
DOI: 10.1007/s00204-024-03844-w.
A novel metric-based approach of scoring early host immune response from oro-nasopharyngeal swabs predicts COVID-19 outcome.
Rajput Y, Neral A, Sherwani N, Jain V, Sahu M, Paikra F
Sci Rep. 2024; 14(1):19510.
PMID: 39174586
PMC: 11341902.
DOI: 10.1038/s41598-024-70161-8.
Mouse adaptation of human inflammatory bowel diseases microbiota enhances colonization efficiency and alters microbiome aggressiveness depending on the recipient colonic inflammatory environment.
Gray S, Moss A, Herzog J, Kashiwagi S, Liu B, Young J
Microbiome. 2024; 12(1):147.
PMID: 39113097
PMC: 11304999.
DOI: 10.1186/s40168-024-01857-2.
Assessment of the piroxicam-incited model of synchronized colitis in T-cell receptor alpha chain-deficient mice.
Lange M, Bescucci D, Boras V, Montina T, Inglis G
Animal Model Exp Med. 2024; 7(4):533-543.
PMID: 38992956
PMC: 11369028.
DOI: 10.1002/ame2.12456.
Enhanced microbiota profiling in patients with quiescent Crohn's disease through comparison with paired healthy first-degree relatives.
Chen W, Li Y, Wang W, Gao S, Hu J, Xiang B
Cell Rep Med. 2024; 5(7):101624.
PMID: 38942021
PMC: 11293350.
DOI: 10.1016/j.xcrm.2024.101624.
Inflammatory proteins may mediate the causal relationship between gut microbiota and inflammatory bowel disease: A mediation and multivariable Mendelian randomization study.
Huang Y, Zheng J, Shi Z, Chen H, Wang X, Kong F
Medicine (Baltimore). 2024; 103(25):e38551.
PMID: 38905376
PMC: 11191895.
DOI: 10.1097/MD.0000000000038551.
IL-10 Neutralization Attenuates Mast Cell Responses in a Murine Model of Experimental Food Allergy.
Krajewski D, Ranjitkar S, Tedeschi C, Perez N, Jordan N, Mire M
Immunohorizons. 2024; 8(6):431-441.
PMID: 38888412
PMC: 11220741.
DOI: 10.4049/immunohorizons.2400002.
Mouse IgA modulates human gut microbiota with inflammatory bowel disease patients.
Takahashi K, Morita N, Tamano R, Gao P, Iida N, Andoh A
J Gastroenterol. 2024; 59(9):812-824.
PMID: 38874761
PMC: 11339086.
DOI: 10.1007/s00535-024-02121-y.
Blimp-1 and c-Maf regulate immune gene networks to protect against distinct pathways of pathobiont-induced colitis.
Alvarez-Martinez M, Cox L, Pearson C, Branchett W, Chakravarty P, Wu X
Nat Immunol. 2024; 25(5):886-901.
PMID: 38609547
PMC: 11065689.
DOI: 10.1038/s41590-024-01814-z.